Health Amicus Therapeutics Provides EU Regulatory Update for AT-GAA Eli Pacheco Nov 7, 2022 0 PHILADELPHIA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel…